Alnylam Pharmaceuticals - 株価

ALNY

143.39

毎日の変更:

4.38%

毎年:

26.46%

価格 日 年
Takeda 3,756.00 -24.00 -0.63% -1.60%
Acadia Pharmaceuticals 48.98 3.16 6.90% 16.87%
Agios Pharmaceuticals 48.89 1.56 3.30% 4.24%
Alnylam Pharmaceuticals 143.39 6.02 4.38% 26.46%
Alexion Pharmaceuticals 150.10 1.64 1.10% 63.19%
Amgen 227.73 5.82 2.62% 8.11%
Arena Pharmaceuticals 73.57 2.06 2.88% 59.83%
Arrowhead Research 69.00 -0.56 -0.81% 106.59%
Avrobio Inc 10.54 -0.48 -4.36% -48.88%
BioCryst Pharmaceuticals 11.15 0.23 2.11% 171.29%
Bluebird Bio 28.68 0.74 2.65% -57.92%
BioMarin Pharmaceutical 77.73 1.38 1.81% -17.55%
Dicerna Pharmaceuticals 27.40 0.34 1.26% 39.09%
GW Pharmaceuticals 214.94 0.77 0.36% 122.14%
Intercept Pharmaceuticals 20.66 1.33 6.88% -77.40%
YTE 80.26 2.76 3.56% 5.55%
Ionis Pharmaceuticals 52.68 1.29 2.52% -1.73%
Moderna Inc 131.97 -0.34 -0.25% 345.68%
Mirati Therapeutics 190.58 9.58 5.29% 115.98%
Neurocrine Biosciences 93.23 0.26 0.28% 0.18%
Novartis 83.50 -4.06 -4.64% -2.69%
PTC Therapeutics 60.14 2.27 3.92% 9.23%
Ultragenyx Pharmaceutical 118.50 -0.13 -0.11% 135.49%
Regeneron Pharmaceuticals 461.57 12.19 2.71% -6.65%
Regulus Therapeutics 1.30 0.15 13.04% 92.59%
Sangamo BioSciences 11.36 0.13 1.16% 37.70%
Sanofi 45.46 0.67 1.46% -6.15%
Sarepta Therapeutics 84.79 2.63 3.20% -27.59%
Vertex Pharmaceuticals 211.98 4.19 2.02% -9.22%
Xencor 44.90 0.71 1.61% 42.36%

価格 日 年
NASDAQ 12920 196.68 1.55% 50.66%

ALNY:US
資産
現金と同等
売上原価
流動資産
流動負債
負債
配当率
EBIT
EBITDA
株当たりのEPS利益
自己資本および準備金
売上総利益
債務の支払利息
借入資本
時価総額
当期純利益
営業経費
営業利益
普通株資本
税引前利益
販売収入
販売および管理費
株式
貿易債権者
貿易債務者